Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sqz Biotechnologies Company (NY: SQZ )

3.100 -0.080 (-2.52%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,512
Open 3.160
Bid (Size) 3.000 (3)
Ask (Size) 3.470 (10)
Prev. Close 3.180
Today's Range 3.020 - 3.240
52wk Range 2.730 - 16.17
Shares Outstanding 28,148,125
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
From SQZ Biotechnologies Company
Via Business Wire
SQZ Biotechnologies Announces Generation of Dopaminergic Neurons from Human Pluripotent Stem Cells Through Single-Step Delivery of Six Cell-Fate Encoding RNAs
From SQZ Biotechnologies Company
Via Business Wire

Performance

YTD
-69.79%
-69.79%
1 Month
-9.36%
-9.36%
3 Month
-38.00%
-38.00%
6 Month
-69.79%
-69.79%
1 Year
-78.93%
-78.93%

More News

Read More
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Looking Into SQZ Biotechnologies's Return On Capital Employed
Via Benzinga
SQZ Biotechnologies to Present at Jefferies Healthcare Conference
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Appoints Marshelle Smith Warren, M.D., as Chief Medical Officer
From SQZ Biotechnologies
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022
Via Benzinga
SQZ Biotechnologies Announces Integrated Point-of-Care Cell Therapy Manufacturing System Demonstrated Comparable or Better Performance Than a More Conventional Clean Room-Based Process
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Reports First Quarter 2022 Financial Results and Recent Portfolio Updates
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies to Host Live & Virtual R&D Investor Event on May 19, 2022
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Announces First Data Presentation on Non-Clinical Studies of Point-of-Care Manufacturing System and Collaboration with STEMCELL Technologies on Research-Use-Only System to Fuel Preclinical Research
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies to Present at Upcoming Investor Conferences
From SQZ Biotechnologies
Via Business Wire
Mid-Morning Market Update: Markets Open Higher; US Economy Contracts 1.4% In Q1
Via Benzinga
74 Biggest Movers From Yesterday
Via Benzinga
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
Via Benzinga
48 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
28 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
SQZ Biotechnologies Receives FDA Fast Track Designation for SQZ-PBMC-HPV for the Treatment of HPV16+ Tumors
Via Benzinga
SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors
From SQZ Biotechnologies
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies to Present at Upcoming Investor Conferences
From SQZ Biotechnologies
Via Business Wire
SQZ Biotechnologies Publishes Comprehensive Preclinical Research on SQZ® TAC Platform’s Ability to Induce Multiple Key Mechanisms of Antigen-Specific Tolerance and Protect Against Type 1 Diabetes
From SQZ Biotechnologies
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.